BioCentury
ARTICLE | Clinical News

Adempas riociguat: Final Phase IIIb data

September 12, 2016 7:00 AM UTC

Final data from 61 PAH patients who had an insufficient response to treatment with phosphodiesterase-5 (PDE-5) inhibitors alone or in combination with an endothelin receptor antagonist in the open-la...